A new Biology Direct study shows that periplocin suppresses osteosarcoma cell proliferation and tumor growth in preclinical ...

Researchers report that the circular RNA circMAP2K4 promotes osteosarcoma progression by sponging miR-515-5p and derepressing ...

The antibody-drug conjugate risvutatug rezetecan could be a major advance for patients with relapsed or refractory ...

Novel B7-H3-targeted drug significantly improved progression-free survival versus chemothe ...

BlackRock ETF Trust II - iShares Flexible Income Active ETF's filing packet contains an announcement from GSK plc regarding positive results from its ARTEMIS-011 study. The pivotal phase III trial in ...

The osteosarcoma treatment pipeline is gradually expanding, with emerging therapies such as OST-HER2 (OS Therapies), DANYELZA (naxitamab-gqgk; SERB Pharmaceutical), Vactosertib (MedPacto), Risvutatug ...

A research team at Johns Hopkins Medicine has created and trained a machine learning model to calculate percent necrosis (PN)—or, what percentage of a tumor is "dead" and no longer active—in patients ...

Scientists co-led by St. Jude Children's Research Hospital have identified a potential therapeutic vulnerability in some ...

The strangely named hedgehog pathway that's crucial to bone growth has emerged as a key in the fight to treat the bone cancer osteosarcoma. Osteosarcoma is a type of bone cancer that primarily affects ...

Osteosarcoma remains one of the most aggressive primary malignant bone tumor, despite all the treatment options available, there has been little progress in osteosarcoma treatment in children and ...

Charlotte swam in a private Los Angeles pool after her owner’s request for one more day in the water was answered. The outing ...